Pfizer (United States)-ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2022

  1. Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study)

    Lung Cancer, Vol. 173, pp. 83-93

2016

  1. Psychometric attributes of the Cervantes short-form questionnaire for measuring health-related quality of life in menopausal women

    Maturitas, Vol. 84, pp. 55-62

2015

  1. Disability-adjusted-life-years losses in postmenopausal women with osteoporosis: A burden of illness study Global health

    BMC Public Health, Vol. 15, Núm. 1

2014

  1. Impact of osteoporosis and bone fracture on health-related quality of life in postmenopausal women

    Climacteric, Vol. 17, Núm. 1, pp. 60-70

2013

  1. Clinical profile of Spanish postmenopausal women with a diagnosis of osteoporosis and risk factors for endometrial pathology, breast cancer, and cardiovascular disease

    Menopause, Vol. 20, Núm. 8, pp. 852-859

  2. Microbial aetiology of healthcare associated pneumonia in Spain: A prospective, multicentre, case-control study

    Thorax, Vol. 68, Núm. 11, pp. 1007-1014

2008

  1. The exon 3-deleted/full-length growth hormone receptor polymorphism does not influence the effect of puberty or growth hormone therapy on glucose homeostasis in short non-growth hormone-deficient small-for-gestational-age children: Results from a two-year controlled prospective study

    Journal of Clinical Endocrinology and Metabolism, Vol. 93, Núm. 7, pp. 2709-2715

2006

  1. Exon 3-deleted/full-length growth hormone receptor polymorphism genotype frequencies in Spanish short small-for-gestational-age (SGA) children and adolescents (n = 247) and in an adult control population (n = 289) show increased fl/fl in short SGA

    Journal of Clinical Endocrinology and Metabolism, Vol. 91, Núm. 12, pp. 5038-5043